Calyxt and cibus announce definitive merger agreement to create industry-leading precision gene editing and trait licensing company

– the merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the availability of renewable low-carbon ingredients – – upon closure of the merger, rory riggs, cibus co-founder, will become c hief executive officer and chairman of the combined company and the cibus leadership team will lead the new organization – roseville, minn. and san diego , jan. 17, 2023 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, and cibus, a leader in precision gene editing in agriculture, today announced that both companies have entered into a definitive merger agreement under which calyxt and cibus will merge in an all-stock transaction.
CLXT Ratings Summary
CLXT Quant Ranking